Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,775 GBX | -0.48% | -1.36% | +22.40% |
May. 17 | UK's FTSE 100 Closes Lower Amid Inflation Focus | MT |
May. 17 | Marti Technologies Hires Oguz Erkan as CFO | MT |
Sales 2024 * | 31.63B 40.17B | Sales 2025 * | 33.58B 42.65B | Capitalization | 72.39B 91.93B |
---|---|---|---|---|---|
Net income 2024 * | 5.54B 7.04B | Net income 2025 * | 6.49B 8.25B | EV / Sales 2024 * | 2.68 x |
Net Debt 2024 * | 12.29B 15.6B | Net Debt 2025 * | 9.07B 11.52B | EV / Sales 2025 * | 2.43 x |
P/E ratio 2024 * |
13.1
x | P/E ratio 2025 * |
11.2
x | Employees | 70,212 |
Yield 2024 * |
3.43% | Yield 2025 * |
3.56% | Free-Float | 94.54% |
Latest transcript on GSK plc
1 day | -0.48% | ||
1 week | -1.36% | ||
Current month | +6.10% | ||
1 month | +11.64% | ||
3 months | +5.88% | ||
6 months | +25.83% | ||
Current year | +22.40% |
Managers | Title | Age | Since |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 10-04-30 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
James Ford
CMP | Compliance Officer | - | 95-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 23-04-30 |
Jonathan Symonds
CHM | Chairman | 66 | 19-08-31 |
Hal Barron
BRD | Director/Board Member | 62 | 17-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.17% | 11 M€ | +0.83% | - | |
3.15% | 17 M€ | +7.73% | - | |
2.51% | 7 M€ | +9.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1,775 | -0.48% | 9,685,470 |
24-05-16 | 1,784 | -1.60% | 5,275,162 |
24-05-15 | 1,812 | +0.14% | 4,861,330 |
24-05-14 | 1,810 | 0.00% | 4,739,267 |
24-05-13 | 1,810 | +0.58% | 4,236,369 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.40% | 91.97B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- GSK Stock